PINX: TGRP
- Last Close 0.55
- Sector Healthcare
- Industry Biotechnology
- Investment Style
- Day Range 0.55 – 0.55
- Year Range 0.38 – 3.75
- Market Cap 95.7000 Mil
- Volume / Avg 174.0 / 600.8
- Price / Sales 121.34
- Price / Book —
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis TGRP
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile TGRP
Nanopharmaceutics Inc is a clinical-stage specialty pharmaceutical company. It is engaged in developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. The company's pipeline products include Triapine, Ammonium Tetrathiomolybdate, and Aza-TdC targeting cancer; NanoBUP, PRX-3140, NP-18-2, and NP-18-3 targeting CNS; and Ramoplanin and NanoDOX.
Our Quantitative Research team models direct competitors or comparable companies from a bottom-up perspective to find companies describing their business in a similar fashion.
Nanopharmaceutics Inc
PINX: TGRP
| Uniti Group Ltd Ordinary Shares
XASX: UWL
| Time Dotcom Bhd
XKLS: 5031
| Hutchison Telecommunications (Australia) Ltd
XASX: HTA
| |
Price
| 0.55 | — | — | 0.04 |
Currency
| USD | — | — | AUD |
Change
| $0.00 (0.00%) | — | — | $0.01 (11.11%) |
Market Cap
| 95.70 Mil | — | — | 542.90 Mil |
Industry
| Biotechnology | Telecom Services | Telecom Services | Telecom Services |
Sector
|
Healthcare
|
Communication Services
|
Communication Services
|
Communication Services
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Nanopharmaceutics Inc Stock
No. TGRP does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
TGRP’s market cap is 95.70 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
TGRP’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare TGRP’s historical performance against its industry peers and the overall market.